PREVALENCE OF HUMAN PAPILOMAVIRUS IN SALIVA OF PATIENTS WITH HIV

Objective: To identify the presence of high-risk serotypes (subtypes 16 and 18) of human papillomavirus (HPV) in the saliva of patients with human immunodeficiency virus (HIV). Study Design: Observational cross-sectional study with a sample of 90 patients of both genders, between June and December 2014. An interview was conducted to identify the sociodemographic profile of the sample. A saliva collection was performed employing falcon tubes and solution for mouthwash with 5% sucrose, with subsequent freezer storage at –20°C. The identification of HPV virus and genotyping for serotype 16 and 18 was by standard polymerase chain reaction (PCR). Results: The predominant sample was male (65.6%), with a mean age of 38.8 years, ranging from 18 to 69 years, and a mean family income of 1.95 minimum wages (SD = 1.37). Specifically on the detection of HPV, 23 of 90 (25.6%) of the sample population evidenced the presence of the infection in the individuals surveyed. Serotypes 16 and 18 were present in 8 of 90 (8.9%) of the entire sample and 8 of 23 (4.7%) if only HPV-infected. Conclusion: HPV coinfection is commonly observed in patients with HIV.